Showing 1 - 8 results of 8 for search 'K. Pappa', query time: 0.04s
Refine Results
-
1
Reconstruction of oral cavity defects using myogenous‐only scapular tip free‐flaps by Blair M. Barton, Andrew K. Pappa, Jeffrey Blumberg, Samip Patel
Published 2022-08-01
Article -
2
Prediction of Long-Term Survival after Coronary Artery Bypass with Bilateral Internal Thoracic Artery Grafting: External Validation of A Contemporary Nomogram by Ioannis K. Toumpoulis, Dimitrios A. Kanistras, Christina K. Pappa, Zoi Zagoriti, Constantine E. Anagnostopoulos, Stavros K. Toumpoulis
Published 2022-11-01
Article -
3
In Situ Radioactivity Measurements and Water Flow Characteristics of a Thermal Spring in Gera Gulf, Lesvos Island, Greece by Christos Tsabaris, Vassilis Zervakis, Spyros Saitanis, Dionisis Patiris, Filothei K. Pappa, Antonios Velegrakis, Stylianos Alexakis, Sotirios Kioroglou
Published 2023-04-01
Article -
4
-
5
Provenance of Coastal and Seabed Sediments Relative to Mining and Processing Wastes: The Case of Lavrion, Attiki Peninsula, Greece by Stavros Savvas Triantafyllidis, Georgios Anastasakis, Anastasios Papanastasiou, Charalambos Stylianou, Nikolaos Kavros, Filothei K. Pappa, Stylianos Fotios Tombros, Michalis Fitros, Vasilios Skliros
Published 2023-12-01
Article -
6
In Situ Radioactivity Maps and Trace Metal Concentrations in Beach Sands of a Mining Coastal Area at North Aegean, Greece by Christos Tsabaris, Dionisis L. Patiris, Rosalinda Adams, Julian Castillo, Maria F. Henriquez, Caroline Hurtado, Lesley Munoz, Leonidas Kalpaxis, Mariana Verri, Stylianos Alexakis, Filothei K. Pappa, Angelos Lampousis
Published 2023-06-01
Article -
7
Switching to DTG/3TC fixed-dose combination (FDC) Is non-inferior to continuing a TAF-based regimen in maintaining virologic suppression through 48 weeks (TANGO Study) by J. Van Wyk, F. Ajana, F. Bisshop, S. De Wit, Y. Osiyemi, J. Portilla, J. Routy, C. Wyen, M. Ait-Khaled, M. Nascimento, K. Pappa, R. Wang, J. Wright, A. Tenorio, B. Wynne, M. Aboud, M. Gartland, K. Smith, Y. El-Bahy
Published 2020-02-01
Article -
8
Durable Efficacy of Dolutegravir (DTG) Plus Lamivudine (3TC) in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI Studies by P. Cahn, J. Sierra Madero, J. Arribas, A. Antinori, R. Ortiz, A. Clarke, C. Hung, J. Rockstroh, P. Girard, J. Sievers, C. Man, R. Urbaityte, M. Underwood, A. Tenorio, K. Pappa, B. Wynne, M. Gartland, M. Aboud, J. van Wyk, K. Smith, Y. El-Bahy
Published 2020-02-01
Article